Aquinox Pharmaceuticals Stock Price Up 6.6% Following Analyst Upgrade (AQXP)

Aquinox Pharma was just $1.76 a share on Thursday. Because the little known pharmaceutical company keeps rising so high so fast that it’s hitting the auto-stop threshold that requires shares halt.

08/10/2015- Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on Aquinox Pharmaceuticals Inc(NASDAQ:AQXP), Voltari Corp (NASDAQ:VLTC), Inovio Pharmaceuticals Inc (NYSEMKT:INO).

But on Tuesday, the shares fell as much as 18% at one point before staging a huge comeback in the last half hour of trading to finish the day up 11%.

Why the gold rush? Pharmaceuticals – NEC Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, publicized results from secondary endpoints from its Phase 2 LEADERSHIP trial with AQX-1125 in patients with bladder pain syndrome/interstitial cystitis (BPS/IC). Aquinox Pharmaceuticals traded as high as $30.00 and last traded at $20.13, with a volume of 7,209,089 shares trading hands. The company has a 50 day moving average of $4.38 and a 200-day moving average of $7.76.

Aquinox Pharmaceuticals Inc(NASDAQ:AQXP) ‘s stock soared 208.93% to $32.19.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) reported financial results for the quarter ended June 30, 2015. Aquinox Pharmaceuticals Inc (AQXP) has a price to book ratio of 0.64. The company shares have rallied 37.83% in the past 52 Weeks.

There are only 4.5 million shares available for public investors. The consensus target price stands at $5. 1 analysts have rated the company as a strong buy. Jefferies Group cut shares of Aquinox Pharmaceuticals from a “buy” rating to a “hold” rating and decreased their target price for the stock from $13.00 to $2.00 in a research note on Friday, July 10th.

Twitter, Inc. (TWTR) is up $0.45, or 1.66%, at $27.49, following a New York Post article that seems to suggest the microblogging service is considering Intel (INTC) President Renée James for CEO. The Reporting Persons may acquire additional securities of the Issuer, including shares of common stock, in such financings or by means of open market purchases, privately negotiated purchases, or otherwise.